Research progress on the relationship between LINC01018-E2F1-CDK6 and malignant tumor / 中国医师杂志
Journal of Chinese Physician
; (12): 634-636, 2021.
Article
in Zh
| WPRIM
| ID: wpr-884096
Responsible library:
WPRO
ABSTRACT
It is known that LINC01018 and CDK6 are associated with the occurrence, progression and recurrence of malignant tumor. Our preliminary data showed that the expression of LINC01018 was down-regulated and that of CDK6 was up-regulated, which were related with the malignancy grade. Bioinformatics suggested that E2F1 binding site exist in the CDK6 promoter region, and LINC01018 might interact with E2F1. Thus we speculate that the expression of LINC01018 in malignant tumor is decreased. The interaction between LINC01018 and E2F1 activates E2F1, promotes the transcription activation of CDK6, and affects tumor proliferation, invasion and metastasis. All these are expected to reveal the effect and mechanisms of LINC01018 in the development and regulation of malignant tumor, and provide new ideas and evidences for its treatment.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Chinese Physician
Year:
2021
Type:
Article